Variant report

Variant	rs286922
Chromosome Location	chr11:34643442-34643443
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	FOXA1	chr11:34643334-34643722	T-47D	breast:	n/a	n/a
2	FOXA2	chr11:34643342-34643726	HepG2	liver:	n/a	n/a
3	MAFK	chr11:34643407-34643749	K562	blood:	n/a	chr11:34643596-34643606 chr11:34643597-34643606
4	FOXA1	chr11:34643272-34643651	HepG2	liver:	n/a	n/a
5	FOXA1	chr11:34643265-34643703	T-47D	breast:	n/a	n/a
6	YY1	chr11:34643440-34643816	K562	blood:	n/a	chr11:34643558-34643574
7	FOXA1	chr11:34643310-34643755	HepG2	liver:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:34642981..34644601-chr11:34653348..34655427,2	K562	blood:
2	chr11:34643086..34644601-chr11:34653927..34655826,2	K562	blood:
3	chr11:34641972..34644254-chr11:34644762..34647514,2	MCF-7	breast:

Variant related genes	Relation type
EHF	TF binding region
ENSG00000135373	Chromatin interaction

Extended variants
information (count: 16 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:3)

rs_ID	r²[population]
rs286915	0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs286924	0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs286928	0.94[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv832116	chr11:34539536-34673900	Flanking Active TSS Enhancers Active TSS Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
2	nsv832117	chr11:34639008-34831199	Enhancers Flanking Active TSS Active TSS Weak transcription Strong transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
3	nsv1045130	chr11:34641598-34777725	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
4	nsv1052192	chr11:34641598-34781288	ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
5	nsv1051492	chr11:34641598-34789331	Weak transcription Enhancers Active TSS Flanking Active TSS ZNF genes & repeats Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
6	nsv1052008	chr11:34641598-34794024	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
7	nsv467788	chr11:34642493-34770494	Weak transcription Flanking Active TSS Enhancers Genic enhancers Active TSS Bivalent Enhancer ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
8	nsv553998	chr11:34642493-34770494	Enhancers Strong transcription Active TSS ZNF genes & repeats Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
9	nsv518807	chr11:34642493-34780936	Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
10	nsv519718	chr11:34642493-34780936	Weak transcription Strong transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
11	nsv467789	chr11:34642493-34780936	Enhancers Weak transcription Strong transcription ZNF genes & repeats Genic enhancers Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
12	nsv467790	chr11:34642493-34780936	Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases
13	nsv553999	chr11:34642493-34780936	Flanking Active TSS Weak transcription Enhancers Active TSS ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	5 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:50 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:34608400-34643600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr11:34636200-34644000	Enhancers	K562	blood
3	chr11:34637800-34649200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr11:34639800-34653800	Weak transcription	Right Atrium	heart
5	chr11:34641800-34644400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr11:34642000-34646800	Active TSS	Esophagus	oesophagus
7	chr11:34642000-34647200	Active TSS	Rectal Smooth Muscle	rectum
8	chr11:34642200-34643600	Active TSS	Pancreas	Pancrea
9	chr11:34642200-34646600	Active TSS	Rectal Mucosa Donor 29	rectum
10	chr11:34642200-34646800	Active TSS	Small Intestine	intestine
11	chr11:34642400-34644400	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr11:34642400-34644600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
13	chr11:34642400-34645400	Active TSS	Colonic Mucosa	Colon
14	chr11:34642400-34645400	Active TSS	Duodenum Mucosa	Duodenum
15	chr11:34642400-34646200	Active TSS	Rectal Mucosa Donor 31	rectum
16	chr11:34642400-34646600	Active TSS	Stomach Mucosa	stomach
17	chr11:34642600-34644000	Active TSS	Fetal Kidney	kidney
18	chr11:34642600-34644200	Active TSS	Fetal Stomach	stomach
19	chr11:34642600-34644200	Flanking Active TSS	HMEC	breast
20	chr11:34642800-34643600	Weak transcription	Fetal Intestine Large	intestine
21	chr11:34642800-34647000	Active TSS	Duodenum Smooth Muscle	Duodenum
22	chr11:34642800-34647200	Active TSS	Gastric	stomach
23	chr11:34642800-34647200	Active TSS	Sigmoid Colon	Sigmoid Colon
24	chr11:34643000-34644000	Enhancers	Brain Substantia Nigra	brain
25	chr11:34643000-34644200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr11:34643000-34644200	Enhancers	Brain Anterior Caudate	brain
27	chr11:34643200-34643600	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
28	chr11:34643200-34644000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr11:34643200-34644000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr11:34643200-34644000	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
31	chr11:34643200-34644000	Flanking Active TSS	Fetal Intestine Small	intestine
32	chr11:34643200-34644000	Active TSS	Lung	lung
33	chr11:34643200-34644200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr11:34643200-34644200	Enhancers	Brain Hippocampus Middle	brain
35	chr11:34643200-34644200	Enhancers	HepG2	liver
36	chr11:34643200-34644400	Enhancers	Brain Inferior Temporal Lobe	brain
37	chr11:34643400-34643800	Enhancers	HSMM	muscle
38	chr11:34643400-34643800	Enhancers	NH-A	brain
39	chr11:34643400-34643800	Flanking Active TSS	NHEK	skin
40	chr11:34643400-34644000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr11:34643400-34644000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr11:34643400-34644000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr11:34643400-34644000	Enhancers	Brain Cingulate Gyrus	brain
44	chr11:34643400-34644000	Enhancers	A549	lung
45	chr11:34643400-34644000	Enhancers	Hela-S3	cervix
46	chr11:34643400-34644000	Enhancers	HSMMtube	muscle
47	chr11:34643400-34644000	Enhancers	NHDF-Ad	bronchial
48	chr11:34643400-34644000	Enhancers	NHLF	lung
49	chr11:34643400-34644000	Enhancers	Osteobl	bone
50	chr11:34643400-34645200	Weak transcription	Primary monocytes fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links